Award
NIH Reporter #5R01CA295997-02
Mechanisms and Consequences of PAX2 Inactivation in the Initiation of Endometrial Carcinogenesis
Recipient
Not specified
Award Amount
$551,975.00
Ceiling
$551,975.00
Awarded
December 05, 2025
Identifier
5R01CA295997-02
Research project awarded by the National Cancer Institute to study the role of PAX2 in endometrial cancer, with an award amount of approximately $551,975 for fiscal year 2026.
Description
The project focuses on studying PAX2 silencing and its role in endometrial cancer. It involves state-of-the-art methods, patient specimens, cell line, and animal models to understand the epigenetic repression of PAX2 and its tumor suppressor functions.